Literature DB >> 26051078

Interferon Gamma-treated Dental Pulp Stem Cells Promote Human Mesenchymal Stem Cell Migration In Vitro.

Chelsee Strojny1, Michael Boyle1, Amelia Bartholomew2, Premanand Sundivakkam3, Satish Alapati4.   

Abstract

INTRODUCTION: Chronic inflammation disrupts dental pulp regeneration by disintegrating the recruitment process of progenitors for repair. Bone marrow-derived mesenchymal stem cells (BM-MSCs) share the common features with dental pulp stem cells (DPSCs). The aim of the study was to investigate the migration of BM-MSCs toward DPSCs in response to inflammatory chemoattractants. Additionally, our studies also delineated the signaling mechanisms from BM-MSCs in mediating the proliferation and differentiation of DPSCs in vitro.
METHODS: Human DPSCs and BM-MSCs between passages 2 and 4 were used and were grown in odontogenic differentiation medium. Mineralization was determined by alizarin red staining analysis. Migration was assessed using crystal violet staining in cells grown in Boyden chamber Transwell inserts (Corning Inc Foundation, Tewksbury, MA). The mineralization potential of DPSCs was evaluated using alkaline phosphatase activity assay. Real-time polymerase chain reaction analysis was performed to assess the gene expression profile of chemokine (C-X-C motif) ligand (Cxcl) 3, 5, 6, 10, 11, 12, 14, and 16; stromal cell-derived factor (SDF) α; vascular endothelial growth factor; and fibroblast growth factor.
RESULTS: Interferon gamma (FN-γ) treatment significantly abrogated the differentiation potential of DPSCs as shown by using alizarin red and alkaline phosphatase activity analysis. An increase in the migration of BM-MSCs was documented when cocultured with IFN-γ-treated DPSCs. RNA expression studies showed an increase in the levels of Cxcl6 and Cxcl12 in BM-MSCs when cocultured with IFN-γ-treated DPSCs. Additionally, an up-regulation of proangiogenic factors vascular endothelial growth factor and fibroblast growth factor were observed in DPSCs exposed to IFN-γ.
CONCLUSIONS: Our findings indicate that inflamed IFN-γ-treated DPSCs release factors (presumably Cxcl6 and 12) that contribute to the homing of MSCs. This model might provide a potential research tool for studying MSC-DPSC cross talk and for future studies involving the recruitment and sustainability of progenitor stem cells sustaining the inflammatory cascade to treat pulp inflammation.
Copyright © 2015 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow–derived mesenchymal stem cells; dental pulp stem cells; inflammation; interferon-γ; migration; regenerative endodontics

Mesh:

Substances:

Year:  2015        PMID: 26051078      PMCID: PMC4624205          DOI: 10.1016/j.joen.2015.02.018

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  28 in total

1.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.

Authors:  S Gronthos; M Mankani; J Brahim; P G Robey; S Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Inflammatory and immunological aspects of dental pulp repair.

Authors:  Michel Goldberg; Jean-Christophe Farges; Sally Lacerda-Pinheiro; Ngampis Six; Nadège Jegat; Frank Decup; Dominique Septier; Florence Carrouel; Stéphanie Durand; Catherine Chaussain-Miller; Pamela Denbesten; Arthur Veis; Anne Poliard
Journal:  Pharmacol Res       Date:  2008-06-17       Impact factor: 7.658

3.  Role of human pulp fibroblasts in angiogenesis.

Authors:  L Tran-Hung; S Mathieu; I About
Journal:  J Dent Res       Date:  2006-09       Impact factor: 6.116

4.  Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis.

Authors:  S Shi; P G Robey; S Gronthos
Journal:  Bone       Date:  2001-12       Impact factor: 4.398

5.  Interaction between marrow-derived human mesenchymal stem cells and peripheral blood mononuclear cells in endothelial cell differentiation.

Authors:  K Joensuu; I Paatero; J J Alm; K Elenius; H T Aro; T J Heino; T A Hentunen
Journal:  Scand J Surg       Date:  2011       Impact factor: 2.360

6.  Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential.

Authors:  Dominick J Alongi; Takayoshi Yamaza; Yingjie Song; Ashraf F Fouad; Elaine E Romberg; Songtao Shi; Rocky S Tuan; George T-J Huang
Journal:  Regen Med       Date:  2010-07       Impact factor: 3.806

7.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

8.  Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization.

Authors:  Xiang Xu; Fangqiang Zhu; Meng Zhang; Dengfen Zeng; Donglin Luo; Guodong Liu; Wenhui Cui; Shali Wang; Wei Guo; Wei Xing; Huaping Liang; Lei Li; Xiaobing Fu; Jianxin Jiang; Hong Huang
Journal:  Cells Tissues Organs       Date:  2012-12-01       Impact factor: 2.481

9.  Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment.

Authors:  James E Ip; Yaojiong Wu; Jing Huang; Lunan Zhang; Richard E Pratt; Victor J Dzau
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

10.  Chronic inflammation and angiogenic signaling axis impairs differentiation of dental-pulp stem cells.

Authors:  Michael Boyle; Crystal Chun; Chelsee Strojny; Raghuvaran Narayanan; Amelia Bartholomew; Premanand Sundivakkam; Satish Alapati
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

View more
  8 in total

Review 1.  Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?

Authors:  John Bianco; Pauline De Berdt; Ronald Deumens; Anne des Rieux
Journal:  Cell Mol Life Sci       Date:  2016-01-14       Impact factor: 9.261

Review 2.  Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and Their Functional Characteristics.

Authors:  David A Castilla-Casadiego; Ana M Reyes-Ramos; Maribella Domenech; Jorge Almodovar
Journal:  Ann Biomed Eng       Date:  2019-11-08       Impact factor: 3.934

3.  IFN-γ regulates human dental pulp stem cells behavior via NF-κB and MAPK signaling.

Authors:  Xinyao He; Wenkai Jiang; Zhirong Luo; Tiejun Qu; Zhihua Wang; Ningning Liu; Yaqing Zhang; Paul R Cooper; Wenxi He
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

4.  Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells.

Authors:  Huarui Ma; Shaoyu Duan; Fei Yan; Haoqing Yang; Yangyang Cao; Lihua Ge; Runtao Gao
Journal:  J Int Med Res       Date:  2019-10-23       Impact factor: 1.671

5.  Effect of using different co-ligands during 99mTc-labeling of J18 peptide on SK-MES-1 cell binding and tumor targeting.

Authors:  Seyed Jalal Hosseinimehr; Soghra Farzipour; Maryam Alvandi; Zahra Shaghaghi
Journal:  Iran J Basic Med Sci       Date:  2021-09       Impact factor: 2.699

6.  A study of the transformation of umbilical cord mesenchymal stem cells by interferon-gamma.

Authors:  Kalina Belemezova; Ivan Bochev; Ekaterina Ivanova-Todorova; Stanimir Kyurkchiev; Dobroslav Kyurkchiev
Journal:  Iran J Basic Med Sci       Date:  2021-09       Impact factor: 2.699

Review 7.  Priming strategies for controlling stem cell fate: Applications and challenges in dental tissue regeneration.

Authors:  Si-Yuan Zhang; Jia-Yin Ren; Bo Yang
Journal:  World J Stem Cells       Date:  2021-11-26       Impact factor: 5.326

8.  CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome.

Authors:  José Luis Torán; Susana Aguilar; Juan Antonio López; Carlos Torroja; Juan Antonio Quintana; Cesar Santiago; José Luis Abad; Patricia Gomes-Alves; Andrés Gonzalez; Juan Antonio Bernal; Luis Jesús Jiménez-Borreguero; Paula Marques Alves; Luis R-Borlado; Jesús Vázquez; Antonio Bernad
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.